Molecular Chaperone Dysfunction in Neurodegenerative Diseases and Effects of Curcumin

The intra- and extracellular accumulation of misfolded and aggregated amyloid proteins is a common feature in several neurodegenerative diseases, which is thought to play a major role in disease severity and progression. The principal machineries maintaining proteostasis are the ubiquitin proteasomal and lysosomal autophagy systems, where heat shock proteins play a crucial role. Many protein aggregates are degraded by the lysosomes, depending on aggregate size, peptide sequence, and degree of misfolding, while others are selectively tagged for removal by heat shock proteins and degraded by either the proteasome or phagosomes. These systems are compromised in different neurodegenerative diseases. Therefore, developing novel targets and classes of therapeutic drugs, which can reduce aggregates and maintain proteostasis in the brains of neurodegenerative models, is vital. Natural products that can modulate heat shock proteins/proteosomal pathway are considered promising for treating neurodegenerative diseases. Here we discuss the current knowledge on the role of HSPs in protein misfolding diseases and knowledge gained from animal models of Alzheimer's disease, tauopathies, and Huntington's diseases. Further, we discuss the emerging treatment regimens for these diseases using natural products, like curcumin, which can augment expression or function of heat shock proteins in the cell.

[1]  John Q. Trojanowski,et al.  Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous α-Synuclein Inclusions of α-Synucleinopathies , 2006 .

[2]  Akihiko Takashima,et al.  Chaperones increase association of tau protein with microtubules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Irene Otte-Höller,et al.  Small heat shock proteins inhibit amyloid-β protein aggregation and cerebrovascular amyloid-β protein toxicity , 2006, Brain Research.

[4]  F. Gomez-Pinilla,et al.  Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma , 2009, Neuroscience.

[5]  D. Selkoe,et al.  Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases , 2004, Nature Cell Biology.

[6]  G. M. Cole,et al.  Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology , 2001, Neurobiology of Aging.

[7]  Tao Zhang,et al.  (-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2. , 2009, Molecular pharmaceutics.

[8]  C. Seidel,et al.  The conformational dynamics of the mitochondrial Hsp70 chaperone. , 2010, Molecular cell.

[9]  C. Cotman,et al.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.

[10]  W. Le,et al.  Are heat shock proteins therapeutic target for Parkinson's disease? , 2006, International journal of biological sciences.

[11]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[12]  Philip L De Jager,et al.  Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.

[13]  E. Masliah,et al.  The many faces of α-synuclein: from structure and toxicity to therapeutic target , 2012, Nature Reviews Neuroscience.

[14]  F. Gomez-Pinilla,et al.  Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition , 2006, Experimental Neurology.

[15]  P. Filipcik,et al.  Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome. , 2012, Journal of Alzheimer's disease : JAD.

[16]  R. Ellis,et al.  Protein misassembly: macromolecular crowding and molecular chaperones. , 2007, Advances in experimental medicine and biology.

[17]  John Hardy,et al.  CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation , 2004 .

[18]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[19]  G. Maru,et al.  Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. , 2010, Journal of agricultural and food chemistry.

[20]  P. Kaur,et al.  Evaluation of molecular chaperons Hsp72 and neuropeptide Y as characteristic markers of adaptogenic activity of plant extracts. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[21]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[22]  Jeff Kuret,et al.  Two motifs within the tau microtubule‐binding domain mediate its association with the hsc70 molecular chaperone , 2008, Journal of neuroscience research.

[23]  A. Al-Majed,et al.  Immediate and Delayed Treatments with Curcumin Prevents Forebrain Ischemia-Induced Neuronal Damage and Oxidative Insult in the Rat Hippocampus , 2006, Neurochemical Research.

[24]  John C Reed,et al.  Heat-shock proteins as regulators of apoptosis , 2003, Oncogene.

[25]  E. Masliah,et al.  Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives , 2011, Neuroscience Research.

[26]  J. Cummings,et al.  A potential role of the curry spice curcumin in Alzheimer's disease. , 2005, Current Alzheimer research.

[27]  L. Thal,et al.  Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role , 2005, Neurobiology of Aging.

[28]  Tack-Joong Kim,et al.  Prevention of Oxidative Stress-Induced Apoptosis of C2C12 Myoblasts by a Cichorium intybus Root Extract , 2013, Bioscience, biotechnology, and biochemistry.

[29]  H. Lilie,et al.  Identification of a redox‐regulated chaperone network , 2004, The EMBO journal.

[30]  Joost Schymkowitz,et al.  The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? , 2010, Alzheimer's Research & Therapy.

[31]  A. Goldberg,et al.  Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.

[32]  Catherine A. Sugar,et al.  Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study , 2012, Alzheimer's Research & Therapy.

[33]  P. Christen,et al.  cis‐Effect of DnaJ on DnaK in ternary complexes with chimeric DnaK/DnaJ‐binding peptides , 2004, FEBS letters.

[34]  G. Giaccone,et al.  Targeting the dynamic HSP90 complex in cancer , 2010, Nature Reviews Cancer.

[35]  P. Workman,et al.  HSP90 as a new therapeutic target for cancer therapy: the story unfolds , 2002, Expert opinion on biological therapy.

[36]  B. Nehru,et al.  Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson's disease in a rotenone-based model , 2014, Neuropharmacology.

[37]  V. Mok,et al.  Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. , 2008, Journal of clinical psychopharmacology.

[38]  D. Dickson,et al.  Molecular Pathogenesis of Genetic and Inherited Diseases Aging Analysis Reveals Slowed Tau Turnover and Enhanced Stress Response in a Mouse Model of Tauopathy , 2008 .

[39]  R. Nixon,et al.  The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.

[40]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[41]  M. Sierks,et al.  Protein Misfolding and Neurodegenerative Diseases , 2014, International journal of cell biology.

[42]  Fei Wang,et al.  Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions. , 2007, Biochemistry.

[43]  A. Ciechanover,et al.  Ubiquitin-dependent Degradation of Certain Protein Substrates in Vitro Requires the Molecular Chaperone Hsc70* , 1997, The Journal of Biological Chemistry.

[44]  R. Roos,et al.  Huntington's disease: a clinical review , 2010, Orphanet journal of rare diseases.

[45]  C. Dobson,et al.  Heat Shock Protein 70 Inhibits α-Synuclein Fibril Formation via Preferential Binding to Prefibrillar Species* , 2005, Journal of Biological Chemistry.

[46]  S. Lindquist,et al.  Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Minton,et al.  Protein aggregation in crowded environments , 2006, Biological chemistry.

[48]  G. Piwien-Pilipuk,et al.  The 90-kDa Heat-shock Protein (Hsp90)-binding Immunophilin FKBP51 Is a Mitochondrial Protein That Translocates to the Nucleus to Protect Cells against Oxidative Stress* , 2011, The Journal of Biological Chemistry.

[49]  Paul Workman,et al.  Inhibitors of the heat shock response: Biology and pharmacology , 2007, FEBS letters.

[50]  P. Binz,et al.  Heat shock proteins in human cancer , 2000, Electrophoresis.

[51]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[52]  Alexandra Flemming,et al.  Infectious disease: Unravelling SARS lethality , 2005, Nature Reviews Drug Discovery.

[53]  Hui Zhou,et al.  Heat shock protein 70 inhibits alpha-synuclein fibril formation via interactions with diverse intermediates. , 2006, Journal of molecular biology.

[54]  D. Rubinsztein,et al.  Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  G. Cole,et al.  The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.

[56]  S. Maeda,et al.  Assembly of two distinct dimers and higher‐order oligomers from full‐length tau , 2007, The European journal of neuroscience.

[57]  Peter Critchley,et al.  Binding of prion proteins to lipid membranes. , 2004, Biochemical and biophysical research communications.

[58]  Martin L. Duennwald,et al.  Small Heat Shock Proteins Potentiate Amyloid Dissolution by Protein Disaggregases from Yeast and Humans , 2012, PLoS biology.

[59]  C. Duyckaerts,et al.  The second brain and Parkinson’s disease , 2009, The European journal of neuroscience.

[60]  N. Hooper,et al.  The prion protein and lipid rafts. , 2006, Molecular membrane biology.

[61]  A. Cuervo,et al.  Age-related Decline in Chaperone-mediated Autophagy* , 2000, The Journal of Biological Chemistry.

[62]  B. Hyman,et al.  Small Heat Shock Proteins Protect Against α-Synuclein-Induced Toxicity and Aggregation , 2006 .

[63]  L. Whitesell,et al.  Altered Hsp90 function in cancer: a unique therapeutic opportunity. , 2004, Molecular cancer therapeutics.

[64]  T. Gasiewicz,et al.  Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. , 2005, Biochemistry.

[65]  T. MacRae,et al.  The Small Heat Shock Proteins and Their Role in Human Disease , 2022 .

[66]  A. Haase,et al.  Increased expression of heat shock protein, transferrin, and beta 2-microglobulin in astrocytes during scrapie. , 1993, Microbial pathogenesis.

[67]  J. Mattick,et al.  Conservation of the regulatory subunit for the Clp ATP-dependent protease in prokaryotes and eukaryotes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Steven P. Gygi,et al.  CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival* , 2004, Journal of Biological Chemistry.

[69]  B. Hyman,et al.  α-Synuclein–enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons , 2001, Neuroscience.

[70]  Xiao-yan Tang,et al.  Epigallocatechin-3-Gallate Suppressed the Over-Expression of HSP 70 and MDR1 Induced by Heat Shock in SGC 7901 , 2008, Journal of chemotherapy.

[71]  M. Rahimtula,et al.  Stress‐mediated signaling in PC12 cells – the role of the small heat shock protein, Hsp27, and Akt in protecting cells from heat stress and nerve growth factor withdrawal , 2002, Journal of neurochemistry.

[72]  A. Fersht,et al.  Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[73]  D. Ehrnhoefer,et al.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.

[74]  B. Blagg,et al.  Gambogic acid, a natural product inhibitor of Hsp90. , 2011, Journal of natural products.

[75]  D. Teplow,et al.  Amyloid β-Protein Assembly and Alzheimer Disease* , 2009, Journal of Biological Chemistry.

[76]  Ruedi Aebersold,et al.  Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics*[boxs] , 2004, Journal of Biological Chemistry.

[77]  R. Turner,et al.  The Chaperone BiP/GRP78 Binds to Amyloid Precursor Protein and Decreases Aβ40 and Aβ42 Secretion* , 1998, The Journal of Biological Chemistry.

[78]  B. Tripathy,et al.  Neuroprotective and Anti-ageing Effects of Curcumin in Aged Rat Brain Regions , 2006, Biogerontology.

[79]  D. Dickson Parkinson's disease and parkinsonism: neuropathology. , 2012, Cold Spring Harbor perspectives in medicine.

[80]  A. Dixit,et al.  A systematic protocol for the characterization of Hsp90 modulators. , 2011, Bioorganic & medicinal chemistry.

[81]  Carol D. Hicks,et al.  Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent α-Synuclein Oligomer Formation and Rescue α-Synuclein-Induced Toxicity , 2010, Journal of Pharmacology and Experimental Therapeutics.

[82]  A. Dennison,et al.  Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration , 2004, British Journal of Cancer.

[83]  G. Bitan,et al.  Neurotoxic protein oligomers — what you see is not always what you get , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[84]  S. N. Witt,et al.  The unfolding story of the Escherichia coli Hsp70 DnaK: is DnaK a holdase or an unfoldase? , 2002, Molecular microbiology.

[85]  B. Hyman,et al.  Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model , 2007, Journal of neurochemistry.

[86]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[87]  Peter M. Douglas,et al.  Prion propagation by Hsp40 molecular chaperones , 2009, Prion.

[88]  M. Chesselet,et al.  Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease , 2012, Molecular Neurodegeneration.

[89]  K. Sarge,et al.  Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response , 2007, Journal of Molecular Medicine.

[90]  D. Selkoe,et al.  In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells* , 2013, The Journal of Biological Chemistry.

[91]  A. Cuervo,et al.  The Chaperone-Mediated Autophagy Receptor Organizes in Dynamic Protein Complexes at the Lysosomal Membrane , 2008, Molecular and Cellular Biology.

[92]  R. Ellis,et al.  Molecular chaperones: assisting assembly in addition to folding. , 2006, Trends in biochemical sciences.

[93]  Juan Song,et al.  Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro. , 2011, The international journal of biochemistry & cell biology.

[94]  J. Klein,et al.  Heat Shock Protein 27 Controls Apoptosis by Regulating Akt Activation* , 2003, Journal of Biological Chemistry.

[95]  B. Henderson,et al.  Chaperonins are cell-signalling proteins: the unfolding biology of molecular chaperones , 2000, Expert Reviews in Molecular Medicine.

[96]  S. Pietrokovski,et al.  Hsp90 Recognizes a Common Surface on Client Kinases* , 2006, Journal of Biological Chemistry.

[97]  E. Wanker,et al.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[98]  P. Workman,et al.  Targeting CDC37: An alternative, kinase-directed strategy for disruption of oncogenic chaperoning , 2009, Cell cycle.

[99]  R. Nixon,et al.  Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[100]  E. Teng,et al.  Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice* , 2012, The Journal of Biological Chemistry.

[101]  E. Katunina,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[102]  James M. Olson,et al.  Therapeutic opportunities in polyglutamine disease , 2001, Nature Medicine.

[103]  F. Geraci,et al.  Hsp70 and Its Molecular Role in Nervous System Diseases , 2011, Biochemistry research international.

[104]  H. Itoh,et al.  Mammalian HSP60 is quickly sorted into the mitochondria under conditions of dehydration. , 2002, European journal of biochemistry.

[105]  N. Nukina,et al.  Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. , 2000, Human molecular genetics.

[106]  A. Klettner The induction of heat shock proteins as a potential strategy to treat neurodegenerative disorders. , 2004, Drug News and Perspectives.

[107]  V. Daggett Structure-function aspects of prion proteins. , 1998, Current opinion in biotechnology.

[108]  L. Stefanis α-Synuclein in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[109]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[110]  Andrew Emili,et al.  Navigating the Chaperone Network: An Integrative Map of Physical and Genetic Interactions Mediated by the Hsp90 Chaperone , 2005, Cell.

[111]  Takashi Morihara,et al.  Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease , 2008, Journal of Pharmacology and Experimental Therapeutics.

[112]  N. Hooper,et al.  The prion protein and lipid rafts (Review) , 2006 .

[113]  H. Kampinga,et al.  Barcoding heat shock proteins to human diseases: looking beyond the heat shock response , 2014, Disease Models & Mechanisms.

[114]  K. Shannon,et al.  Huntington's Disease: Pathological Mechanisms and Therapeutic Strategies , 2007, Cell transplantation.

[115]  J. Tommassen,et al.  Chaperoning Anfinsen: the steric foldases , 2007, Molecular microbiology.

[116]  M. MacDonald,et al.  Huntingtin: a single bait hooks many species , 1998, Current Opinion in Neurobiology.

[117]  S. Lindquist,et al.  HSP100/Clp proteins: a common mechanism explains diverse functions. , 1996, Trends in biochemical sciences.

[118]  G. Kroemer,et al.  Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor , 2003, Oncogene.

[119]  P. Csermely,et al.  Chaperones and aging: role in neurodegeneration and in other civilizational diseases , 2002, Neurochemistry International.

[120]  J. Buchner,et al.  The Hsp90 Chaperone Machinery* , 2008, Journal of Biological Chemistry.

[121]  F. Hartl,et al.  Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein , 2002, Science.

[122]  K. Fischbeck,et al.  Toxic Proteins in Neurodegenerative Disease , 2002, Science.

[123]  H. Matsuzaki,et al.  Activation of protein kinase B (Akt/RAC‐protein kinase) by cellular stress and its association with heat shock protein Hsp27 , 1997, FEBS letters.

[124]  B. Shastry Neurodegenerative disorders of protein aggregation , 2003, Neurochemistry International.

[125]  L. Tutar,et al.  Heat shock proteins; an overview. , 2010, Current pharmaceutical biotechnology.

[126]  K. Kato,et al.  Stimulation of the stress-induced expression of stress proteins by curcumin in cultured cells and in rat tissues in vivo. , 1998, Cell stress & chaperones.

[127]  B. Timmermann,et al.  Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways , 2013, Investigational New Drugs.

[128]  M. Abdulla,et al.  Mechanisms of Gastroprotective Effects of Ethanolic Leaf Extract of Jasminum sambac against HCl/Ethanol-Induced Gastric Mucosal Injury in Rats , 2012, Evidence-based complementary and alternative medicine : eCAM.

[129]  A. Cuervo,et al.  Chaperone-mediated autophagy. , 2008, Methods in molecular biology.

[130]  Sung-Cheng Huang,et al.  [F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: Effects of aging, in vivo blockade, and anti-Aβ antibody treatment , 2011, Neurobiology of Disease.

[131]  Josef M. Penninger,et al.  Heat-shock protein 70 antagonizes apoptosis-inducing factor , 2001, Nature Cell Biology.

[132]  Soojin Lee,et al.  Mechanisms for regulation of Hsp70 function by Hsp40 , 2003, Cell stress & chaperones.

[133]  Michael A. Mancini,et al.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 , 1998, Nature Genetics.